Literature DB >> 9773966

Evaluation of a line immunoblot assay for detection of antibodies recognizing extractable nuclear antigens.

H E Prince1, W R Hogrefe.   

Abstract

Sera (n = 90) giving positive results in a screening test for antibodies to extractable nuclear antigens (ENAs) were tested in a line immunoblot assay that measures antibody reactivity with individual ENAs in a single test field. Results were then compared to those obtained in monospecific ENA antibody enzyme immunoassays (EIAs). Discordant results were resolved by immunodiffusion. Of 540 result pairs (90 sera tested for 6 ENAs [Sm/RNP, Sm, SSA, SSB, Scl-70, Jo-1]), 509 (94%) showed concordance. Immunodiffusion resolved 28 of 31 discordant result pairs in favor of the immunoblot result. After resolution of discordant data, the immunoblot assay exhibited 100% sensitivity for all ENA antibodies except those recognizing Scl-70, for which the sensitivity was 89%; specificity was over 96% for all 6 ENA antibodies. These findings show that a line immunoblot assay for the characterization of ENA antibodies yields results comparable to those obtained using monospecific ENA antibody EIAs. The immunoblot assay is easier and less expensive to perform due to its utilization of a single test field.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773966      PMCID: PMC6807698          DOI: 10.1002/(sici)1098-2825(1998)12:5<320::aid-jcla13>3.0.co;2-x

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  13 in total

Review 1.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  Evaluation of commercial enzyme immunoassays compared to immunofluorescence and double diffusion for autoantibodies associated with autoimmune diseases.

Authors:  K James; G Meek
Journal:  Am J Clin Pathol       Date:  1992-04       Impact factor: 2.493

3.  Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.

Authors:  J Sánchez-Guerrero; R A Lew; A H Fossel; P H Schur
Journal:  Arthritis Rheum       Date:  1996-06

4.  Effective separation of the 52 kDa SSA/Ro polypeptide from the 48 kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis.

Authors:  J P Buyon; S G Slade; E K Chan; E M Tan; R Winchester
Journal:  J Immunol Methods       Date:  1990-05-25       Impact factor: 2.303

5.  Extractable nuclear antigens.

Authors:  T L Moore; T D Weiss; S H Neucks; A R Baldassare; J Zuckner
Journal:  Semin Arthritis Rheum       Date:  1981-05       Impact factor: 5.532

6.  Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

Authors:  G C Sharp; W S Irvin; C M May; H R Holman; F C McDuffie; E V Hess; F R Schmid
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

7.  High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients.

Authors:  J H Shero; B Bordwell; N F Rothfield; W C Earnshaw
Journal:  Science       Date:  1986-02-14       Impact factor: 47.728

Review 8.  Clinical significance of antinuclear antibodies in systemic rheumatic diseases.

Authors:  M Hietarinta; O Lassila
Journal:  Ann Med       Date:  1996-08       Impact factor: 4.709

9.  Evaluation of the RheumaStrip ANA profile test: a rapid test strip procedure for simultaneously determining antibodies to autoantigens U1-ribonucleoprotein (U1-RNP), Sm, SS-A/Ro, SS-B/La, and to native DNA.

Authors:  H Paxton; T Bendele; L O'Connor; D C Haynes
Journal:  Clin Chem       Date:  1990-05       Impact factor: 8.327

10.  Comparison of three commercially available enzyme immunoassays for the screening of autoantibodies to extractable nuclear antigens.

Authors:  T D Jaskowski; C Schroder; T B Martins; L Mouritsen; H R Hill
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

View more
  4 in total

Review 1.  Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful.

Authors:  Tri Giang Phan; Richard C W Wong; Stephen Adelstein
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

2.  Lupus Heart Disease Modeling with Combination of Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Lupus Patient Serum.

Authors:  Narae Park; Yeri Alice Rim; Hyerin Jung; Yoojun Nam; Ji Hyeon Ju
Journal:  Int J Stem Cells       Date:  2021-12-31       Impact factor: 3.011

Review 3.  Clinical and pathological roles of Ro/SSA autoantibody system.

Authors:  Ryusuke Yoshimi; Atsuhisa Ueda; Keiko Ozato; Yoshiaki Ishigatsubo
Journal:  Clin Dev Immunol       Date:  2012-12-06

4.  Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).

Authors:  Daniel Gagiannis; Julie Steinestel; Carsten Hackenbroch; Benno Schreiner; Michael Hannemann; Wilhelm Bloch; Vincent G Umathum; Niklas Gebauer; Conn Rother; Marcel Stahl; Hanno M Witte; Konrad Steinestel
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.